433 related articles for article (PubMed ID: 9425928)
1. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.
Weltman MD; Farrell GC; Hall P; Ingelman-Sundberg M; Liddle C
Hepatology; 1998 Jan; 27(1):128-33. PubMed ID: 9425928
[TBL] [Abstract][Full Text] [Related]
2. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
[TBL] [Abstract][Full Text] [Related]
3. Study of cytochrome P450 2E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women.
Varela NM; Quiñones LA; Orellana M; Poniachik J; Csendes A; Smok G; Rodrigo R; Cáceres DD; Videla LA
Biol Res; 2008; 41(1):81-92. PubMed ID: 18769766
[TBL] [Abstract][Full Text] [Related]
4. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.
Emery MG; Fisher JM; Chien JY; Kharasch ED; Dellinger EP; Kowdley KV; Thummel KE
Hepatology; 2003 Aug; 38(2):428-35. PubMed ID: 12883487
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical determination of hepatic cytochrome P-4502E1 in formalin-fixed, paraffin-embedded sections.
Cohen PA; Mak KM; Rosman AS; Kessova I; Mishin VM; Koivisto T; Lieber CS
Alcohol Clin Exp Res; 1997 Sep; 21(6):1057-62. PubMed ID: 9309318
[TBL] [Abstract][Full Text] [Related]
6. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA.
Takahashi T; Lasker JM; Rosman AS; Lieber CS
Hepatology; 1993 Feb; 17(2):236-45. PubMed ID: 8428720
[TBL] [Abstract][Full Text] [Related]
7. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.
Leclercq IA; Farrell GC; Field J; Bell DR; Gonzalez FJ; Robertson GR
J Clin Invest; 2000 Apr; 105(8):1067-75. PubMed ID: 10772651
[TBL] [Abstract][Full Text] [Related]
8. Posttranscriptional elevation of cytochrome P450 3A expression.
Zangar RC; Hernandez M; Novak RF
Biochem Biophys Res Commun; 1997 Feb; 231(1):203-5. PubMed ID: 9070249
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome 3A and 2E1 in human liver tissue: Individual variations among normal Japanese subjects.
Hata S; Miki Y; Fujishima F; Sato R; Okaue A; Abe K; Ishida K; Akahira J; Unno M; Sasano H
Life Sci; 2010 Mar; 86(11-12):393-401. PubMed ID: 20102722
[TBL] [Abstract][Full Text] [Related]
10. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.
Kamada Y; Matsumoto H; Tamura S; Fukushima J; Kiso S; Fukui K; Igura T; Maeda N; Kihara S; Funahashi T; Matsuzawa Y; Shimomura I; Hayashi N
J Hepatol; 2007 Oct; 47(4):556-64. PubMed ID: 17459514
[TBL] [Abstract][Full Text] [Related]
11. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
12. Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease.
Prompila N; Wittayalertpanya S; Komolmit P
J Med Assoc Thai; 2008 May; 91(5):733-8. PubMed ID: 18672640
[TBL] [Abstract][Full Text] [Related]
13. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics.
Liangpunsakul S; Kolwankar D; Pinto A; Gorski JC; Hall SD; Chalasani N
Hepatology; 2005 May; 41(5):1144-50. PubMed ID: 15841467
[TBL] [Abstract][Full Text] [Related]
14. Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases.
Niemelä O; Parkkila S; Juvonen RO; Viitala K; Gelboin HV; Pasanen M
J Hepatol; 2000 Dec; 33(6):893-901. PubMed ID: 11131450
[TBL] [Abstract][Full Text] [Related]
15. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.
Chalasani N; Gorski JC; Asghar MS; Asghar A; Foresman B; Hall SD; Crabb DW
Hepatology; 2003 Mar; 37(3):544-50. PubMed ID: 12601351
[TBL] [Abstract][Full Text] [Related]
16. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
[TBL] [Abstract][Full Text] [Related]
17. Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: relation to single strand breaks of DNA.
Villard PH; Seree EM; Re JL; De Meo M; Barra Y; Attolini L; Dumenil G; Catalin J; Durand A; Lacarelle B
Toxicol Appl Pharmacol; 1998 Feb; 148(2):195-204. PubMed ID: 9473526
[TBL] [Abstract][Full Text] [Related]
18. [Role of lipid peroxidation in non-alcoholic steatohepatitis].
Fraenkel E; Lazúrová I; Fehér J
Orv Hetil; 2004 Mar; 145(12):611-8. PubMed ID: 15119115
[TBL] [Abstract][Full Text] [Related]
19. Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease.
Fisher CD; Lickteig AJ; Augustine LM; Ranger-Moore J; Jackson JP; Ferguson SS; Cherrington NJ
Drug Metab Dispos; 2009 Oct; 37(10):2087-94. PubMed ID: 19651758
[TBL] [Abstract][Full Text] [Related]
20. Perivenous expression of ethanol-inducible cytochrome P450 IIE1 in livers from alcoholics and chronically ethanol-fed rats.
Bühler R; Lindros KO; von Boguslawsky K; Kärkkäinen P; Mäkinen J; Ingelman-Sundberg M
Alcohol Alcohol Suppl; 1991; 1():311-5. PubMed ID: 1845553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
